MTOR and type 2 diabetes mellitus: Also, in acute stroke patients with type 2 diabetes, metformin could improve the neurological function and oxidative stress status by the AMPK/mTOR signaling pathway and oxidative stress [51], and in acute ischemic injury, prestroke metformin treatment was neuroprotective involving AMPK reduction [52].